CAS RN: 1313725-88-0
Volitinib
Product Availability
Choose a grade to view its available package options.
2 package records 1 with current stock 2 grade groups
Grade
99% (1)
Moligand™, 10 mM in DMSO (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260314
10mg / 50mg / 250mg
Out of stock
5-7 business days Inquiry
Batch No. Package Availability Lead Time Inquiry
Batchno.20260611
1ml
In stock
Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1313725-88-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
1313725-88-0 / 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine
Standard CAS: 1313725-88-0
Multi CAS: No
Basic Information
copy
CAS
1313725-88-0 copy
Multi CAS
No copy
Molecular Formula
C17H15N9 copy
Molecular Weight
345.400000 copy
Exact Mass
345.145042 copy
SMILES
C[C@@H](C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C copy
InChI
InChI=1S/C17H15N9/c1-11(12-3-4-15-18-5-6-25(15)10-12)26-17-16(22-23-26)19-8-14(21-17)13-7-20-24(2)9-13/h3-11H,1-2H3/t11-/m0/s1 copy
InChIKey
XYDNMOZJKOGZLS-NSHDSACASA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
26 copy
Aromatic heavy atom count
23 copy
Fraction Csp3
0.18 copy
Rotatable bonds
3 copy
H-bond acceptors
9 copy
Molar refractivity
94.33 copy
TPSA
91.61 copy
LogP / Solubility
WLOGP
1.88 copy
MLOGP
1.67 copy
XLogP3
1.5 copy
Consensus LogP
1.68 copy
Log S (ESOL)
-3.62 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.75 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.82 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.49 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
4 copy
Safety & Transport
copy
Pictogram(s)
Health Hazard copy
Signal
Danger copy
GHS Hazard Statements
H360 (75%): May damage fertility or the unborn child [Danger Reproductive toxicity]
H360D (75%): May damage the unborn child [Danger Reproductive toxicity]
H361 (25%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] copy
Precautionary Statement Codes
P203, P280, P318, P405, and P501 copy